AbbVie ABBV
NYSE ABBV
$263.90 -0.10 (-0.04%)
At close: Sep 18, 2026 · 4:00 PM EDT

AbbVie (ABBV) Net Shares Issued and Repurchased (2013 - 2016)

AbbVie's (ABBV) quarterly Net Shares Issued and Repurchased came in at $231000.0 in Q1 2016, up 49.03% year-over-year from $155000.0 in Q2 2015, and down 65.78% quarter-over-quarter from $675000.0 in Q4 2015.

Analysis

AbbVie (ABBV) Net Shares Issued and Repurchased (2013 - 2016) Analysis & Trends

AbbVie (ABBV) has reported Net Shares Issued and Repurchased for 4 consecutive years, with $231000.0 the latest figure, recorded in Q1 2016.

  • On a quarterly basis, Net Shares Issued and Repurchased rose 49.03% year-over-year to $231000.0 in Q1 2016; TTM through Mar 2016 was $231000.0, a 49.03% increase from a year earlier, with the FY2015 full-year figure at $675000.0, up 18.63% from the prior year.
  • Net Shares Issued and Repurchased was $231000.0 for Q1 2016 at AbbVie, down from $675000.0 in the prior quarter.
  • Over five years, Net Shares Issued and Repurchased peaked at $675000.0 in Q4 2015 and troughed at $76000.0 in Q1 2013.
  • A 4-year average of $339428.6 and a median of $231000.0 in 2016 frame the typical range for Net Shares Issued and Repurchased.
  • The widest YoY moves for Net Shares Issued and Repurchased: up 63.16% in 2014, down 4.21% in 2014.
  • Over 4 years, Net Shares Issued and Repurchased stood at $546000.0 in 2013, then grew by 4.21% to $569000.0 in 2014, then advanced by 18.63% to $675000.0 in 2015, then tumbled by 65.78% to $231000.0 in 2016.
  • The last three Net Shares Issued and Repurchased figures came in at $231000.0 (Q1 2016), $675000.0 (Q4 2015), and $155000.0 (Q1 2015), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued and Repurchased (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn -
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn -
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn -
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn -3.07 Bn
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn -
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn -
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn -
8 Revolution Medicines 40.91 Bn 40.91 Bn - -
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn -
10 Incyte 25.18 Bn 20.65 Bn 1.57 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2016 231,000.00
Dec 31, 2015 675,000.00
Mar 31, 2015 155,000.00
Dec 31, 2014 569,000.00
Mar 31, 2014 124,000.00
Dec 31, 2013 546,000.00
Mar 31, 2013 76,000.00